Abstract:Objective: To determine the place of imaging and the performance of different imaging techniques (transvaginal ultrasound with or without Doppler, scoring, CT, MRI) to differentiate benign tumour, borderline ovarian tumour (BOT) and malignant ovarian tumor. Differentiate the histological subtypes of BOT (serous, sero-mucinous, mucinous) and prediction in imaging of the possibility of conservative treatment. Methods: The research was carried out over the last 16 years using the terms "MeSH" based on the query of the Medline® database and supplemented by the review of references contained in the meta-analyzes, systematic reviews and original articles included. Results: Endo-vaginal and suprapubic ultrasonography is recommended for analysis of an ovarian mass (grade A). In the case of ultrasound by a referent, subjective analysis is the recommended technique (grade A). In case of echography by a non-referent, the use of "Simple Rules" is recommended (grade A) and should be best combined with subjective analysis to rejoin the performance of a sonographer refer (grade A). In cases of undetermined ovarian lesions in endovaginal ultrasound and suprapubic ultrasound, it is recommended to perform a pelvic MRI (grade A). The MRI protocol should include T2, T1, T1 sequences with fat saturation, diffusion, injected dynamics, and after gadolinium injection (grade B). To characterize an MRI-adnexal image, it is recommended to include a risk score for malignancy (ADNEX-MR/O-RADS) (grade C) in the report and to formulate an anatomopathological hypothesis (Grade C). The predictive signs of benignity in front of a cyst with endocystic vegetations are the low number, the small size, the presence of calcifications and the absence of Doppler flow in case of size greater than 10mm in echography (LP 4) and a curve of type 1 MRI (LP4). MRI is recommended for suspicious lesions of BOT in ultrasound (grade B) or indeterminate lesions in ultrasound (grade A). There is no data to support the usefulness of CT or PET-CT for BOT. Morphological criteria in ultrasound and MRI exist to differentiate BOT from invasive tumors regardless of grade (NP 2). Pelvic MRI is recommended to characterize a tumor suggestive of ultrasound BOT (grade C). No recommendations can be made about the use of combined ultrasound, biological, and menopausal status scores for the diagnosis of BOT. The diagnostic performance of imaging to detect peritoneal implants of BOT is not known. The assessment of the invasiveness of peritoneal implants of imaging BOT has not been evaluated. The association of macroscopic signs in MRI makes it possible to differentiate the different subtypes - serous, sero-mucinous and mucinous (intestinal type) - of BOT, despite the overlap of certain presentations (LP3). The analysis of macroscopic MRI signs must be performed to differentiate the different subtypes of TFO (grade C). No recommendation can be made on imaging prediction of the possibility of conservative BOT treatment.

MRI Appearances of Ovarian Serous Borderline Tumor: Pathological Correlation

Role of MRI in Characterizing Serous Borderline Ovarian Tumor and Its Subtypes: Correlation of MRI Features with Clinicopathological Characteristics.

MRI Appearances of Mucinous Borderline Ovarian Tumors: Pathological Correlation.

MRI of Borderline Epithelial Ovarian Tumors: Pathologic Correlation and Diagnostic Challenges

Comparison of Benign, Borderline, and Malignant Ovarian Seromucinous Neoplasms on MR Imaging

MRI Features in Differentiation Borderline from Benign Mucinous Ovarian Cystadenoma

Preoperative Sonographic Features of Borderline Tumors of the Ovary

MRI Features and Score for Differentiating Borderline from Malignant Epithelial Ovarian Tumors

Evaluation of Ovarian Tumors with Multidetector Computed Tomography and Tumor Markers: Differentiation of Stage I Serous Borderline Tumors and Stage I Serous Malignant Tumors Presenting As Solid-Cystic Mass

The Comparative Study of MRI Appearances of Ovarian Thecoma with Pathologic Findings

Ovarian Sex Cord-stromal Tumor:MRI Findings Correlated with Pathology

Salient magnetic resonance imaging findings in the differential diagnosis of benign, borderline and malignant ovarian mucinous tumors

Imaging features and differential diagnosis of benign and borderline/malignant ovarian Brenner tumor

Magnetic Resonance Imaging Characteristics of Ovarian Clear Cell Carcinoma

Pure Dysgerminoma of the Ovary: CT and MRI Features with Pathological Correlation in 13 Tumors

Comparative Study of Surgical Pathology and MRI in Ovarian Tumor

CT Diagnosis of Serous Ovarian Neoplasm

MRI diagnosis of malignant ovarian tumors

Differentiation of borderline tumors from type I ovarian epithelial cancers on CT and MR imaging

[Borderline Ovarian Tumours: CNGOF Guidelines for Clinical Practice - Imaging]

Characterization of Ovarian Granulosa Cell Tumors using Magnetic Resonance Imaging